You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Histiocyte sarcoma

Showing 1 - 25 of 1,119
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Langerhans Cell Histiocytosis (LCH), Histiocytoses Erdheim-chester Disease, Histiocytic Sarcoma (HS) Trial in Boston

Active, not recruiting
  • Langerhans Cell Histiocytosis (LCH)
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Aug 26, 2022

Lymphoma, Histiocytic Sarcoma, Follicular Dendritic Cell Sarcoma Trial in Chicago, Boston, Omaha (Pembrolizumab)

Suspended
  • Lymphoma
  • +3 more
  • Chicago, Illinois
  • +3 more
Jan 30, 2023

Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma Trial (Atezolizumab Injection, Bevacizumab, Transarterial

Not yet recruiting
  • Hepatocellular Carcinoma
  • BCLC Stage B Hepatocellular Carcinoma
  • Atezolizumab Injection
  • +2 more
  • (no location specified)
Mar 16, 2023

Sarcoma, Soft Tissue Trial in Changsha (Cardunilizumab)

Active, not recruiting
  • Sarcoma, Soft Tissue
  • Changsha, Hunan, China
    Xiangya Hospital Central South University
Oct 29, 2023

Objective Response, Overall Survival Trial in Beijing (VIA combination treatment)

Completed
  • Objective Response
  • Overall Survival
  • VIA combination treatment
  • Beijing, China
    Peking University People's Hospital
Dec 9, 2022

Metastatic Sarcoma, Sarcoma Trial in Seattle (Assessment, Questionnaire Administration, Interview)

Not yet recruiting
  • Metastatic Sarcoma
  • Sarcoma
  • Assessment
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Apr 27, 2023

Kaposi Sarcoma Trial in Worldwide (Propranolol)

Not yet recruiting
  • Kaposi Sarcoma
  • Buenos Aires, Argentina
  • +8 more
Mar 22, 2023

Sarcoma Trial in Columbus (Educational Intervention, Quality-of-Life Assessment, Survey Administration)

Completed
  • Sarcoma
  • Educational Intervention
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 26, 2022

Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma Trial in Worldwide (AL3818, Dacarbazine, AL3818 or )

Active, not recruiting
  • Alveolar Soft Part Sarcoma
  • +3 more
  • Phoenix, Arizona
  • +22 more
Nov 1, 2022

Soft Tissue Sarcoma Trial (Cadonilimab)

Not yet recruiting
  • Soft Tissue Sarcoma
  • Cadonilimab
  • (no location specified)
Dec 9, 2022

Ewing Sarcoma, Ewing Sarcoma of Bone, Ewing Sarcoma of Soft Tissue Trial in United States (FoundationOne Liquid CDx)

Recruiting
  • Ewing Sarcoma
  • +6 more
  • FoundationOne Liquid CDx
  • Los Angeles, California
  • +14 more
Oct 5, 2023

Rare Histiocytic Disorders (RHDs), Juvenile Xanthogranuloma (JXG), Reticulohistiocytoma (Epithelioid Histiocytoma) Trial in

Active, not recruiting
  • Rare Histiocytic Disorders (RHDs)
  • +7 more
  • Registry study
  • Los Angeles, California
  • +13 more
Dec 13, 2022

Advanced Sarcoma, Metastatic Sarcoma, Soft Tissue Sarcoma Trial (YH001, Envafolimab, Doxorubicin)

Recruiting
  • Advanced Sarcoma
  • +2 more
  • Santa Monica, California
    Sarcoma Oncology Center
Dec 5, 2022

Ewing Sarcoma, Ewing-Like Sarcoma Trial in New York (LY2880070, Gemcitabine)

Recruiting
  • Ewing Sarcoma
  • Ewing-Like Sarcoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Aug 18, 2022

Soft Tissue Sarcoma Trial in Beijing (Fluzoparib, Preoperative moderately fractionated radiotherapay)

Recruiting
  • Soft Tissue Sarcoma
  • Fluzoparib
  • Preoperative moderately fractionated radiotherapay
  • Beijing, Beijing, China
  • +1 more
Jul 3, 2023

Retroperitoneal Sarcoma Trial in Seattle (drug, procedure, radiation)

Not yet recruiting
  • Retroperitoneal Sarcoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 5, 2023

Study on Dynamic CtDNA Analysis in Pediatric Soft Tissue Sarcoma

Recruiting
  • Pediatric Soft Tissue Sarcoma
  • detection and monitoring of cirulating tumor DNA
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Mar 20, 2023

Molecular Mechanism Study of Uterine Sarcoma

Recruiting
  • Uterine Sarcoma
  • Diagnostic biomarker
  • Wuhan, Hubei, China
    Yan Li
May 21, 2023

Sarcoma,Soft Tissue, Brachytherapy, Poly(ADP-ribose) Polymerase Inhibitors Trial in Guangzhou (Fluzoparib, Radioactive particle

Recruiting
  • Sarcoma,Soft Tissue
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 30, 2023

Sarcoma Trial in Portland (Exercise Counseling, Quality-of-Life Assessment, Questionnaire Administration)

Completed
Has Results
  • Sarcoma
  • Exercise Counseling
  • +3 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 12, 2022

Soft Tissue Sarcoma Trial in France (SBRT + MEDI5752)

Not yet recruiting
  • Soft Tissue Sarcoma
  • SBRT + MEDI5752
  • Bordeaux, France
  • +4 more
Apr 7, 2023

Sarcoma,Soft Tissue Trial in Spain (Selinexor 20 MG, Gemcitabine)

Recruiting
  • Sarcoma,Soft Tissue
  • Tenerife, Canarias, Spain
  • +10 more
Oct 27, 2023

Sarcoma, Ewing, Sarcoma Trial in Santa Monica (Combination metyrosine-derivative, low-dose methoxsalen, phenytoin and sirolimus

Active, not recruiting
  • Sarcoma, Ewing
  • Sarcoma
  • Combination metyrosine-derivative, low-dose methoxsalen, phenytoin and sirolimus (MPS)
  • Santa Monica, California
    Sarcoma Oncology Research Center
Jan 19, 2023

Soft Tissue Sarcoma Trial (Candonilimab)

Not yet recruiting
  • Soft Tissue Sarcoma
  • (no location specified)
Jun 22, 2023

Sarcoma, Ewing Trial in China (TK216+Vincristin)

Not yet recruiting
  • Sarcoma, Ewing
  • TK216+Vincristin
  • Beijing, Beijing, China
  • +7 more
Jul 25, 2022